FDA Inspection
Octapharma ABOctapharma AB – FDA Inspection, Oct 3, 2016
Record Details
This FDA Inspection record concerns Octapharma AB, with an inspection on October 3, 2016, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 6b3e378f-099f-4e8b-a570-ba2acbf16cb8
Inspection Facts
- Inspection number
- 994537
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Octapharma AB
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 28, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 20, 2011 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma AB
- FDA Inspection 1218250 - 2023-09-19
- FDA Inspection 1070173 - 2018-09-28
- FDA Inspection 894095 - 2014-04-28
- FDA Inspection 783783 - 2012-01-19
- FDA Inspection 710676 - 2011-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.